Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 2 (50%) |
| No statute on record | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROZOF, TIMOTHY R | 1 | 72.6% | +24.0% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.6% | +18.2% |
| THOMAS, TIMOTHY P | 1 | 26.2% | +38.3% |
| HIBSHMAN, SARAH GRACE | 1 | 40.9% | +46.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17633973 | ENZYME INHIBITORS | THOMAS, TIMOTHY P | 24d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17617439 | TREATMENTS OF HEREDITARY ANGIOEDEMA | HIBSHMAN, SARAH GRACE | 80d overdue |
| 18347815 | POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF | CHANDRAKUMAR, NIZAL S | 36d overdue |
| 17633973 | ENZYME INHIBITORS | THOMAS, TIMOTHY P | 24d overdue |
| 18264810 | TREATMENTS OF HEREDITARY ANGIOEDEMA | ROZOF, TIMOTHY R | 10d overdue |
| Art Unit | Apps |
|---|---|
| 1625 | 2 |
| 1614 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18264810 | TREATMENTS OF HEREDITARY ANGIOEDEMA | ROZOF, TIMOTHY R | 1625 | §102 | Non-Final OA | 10d overdue | Pending | Aug 09, 2023 |
| 18347815 | POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF | CHANDRAKUMAR, NIZAL S | 1625 | Other | Final Rejection | 36d overdue | Pending | Jul 06, 2023 |
| 17633973 | ENZYME INHIBITORS | THOMAS, TIMOTHY P | 1614 | §102 | Non-Final OA | 24d overdue | Pending | Feb 09, 2022 |
| 17617439 | TREATMENTS OF HEREDITARY ANGIOEDEMA | HIBSHMAN, SARAH GRACE | 1693 | Other | Final Rejection | 80d overdue | Pending | Dec 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial